Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Intracranial Injection of NK-92/5.28.z Cells in Patients With Recurrent HER2-positive Glioblastoma (CAR2BRAIN)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03383978
Recruitment Status : Recruiting
First Posted : December 27, 2017
Last Update Posted : September 25, 2020
Sponsor:
Collaborators:
DRK Blutspendedienst Baden-Württemberg-Hessen gGmbH
Georg-Speyer-Haus
LOEWE Center Frankfurt Cancer Institute
German Cancer Research Center
Information provided by (Responsible Party):
Michael Burger, Johann Wolfgang Goethe University Hospital

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : September 2022
Estimated Study Completion Date : December 2022